895
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND project

ORCID Icon, ORCID Icon, , , , , , , , , , , , , , ORCID Icon & show all
Article: 2285454 | Received 24 Aug 2023, Accepted 13 Nov 2023, Published online: 27 Nov 2023

References

  • Bouza E, Munoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents. 2008;32 Suppl 2(Suppl 2):1–11. doi: 10.1016/S0924-8579(08)70006-2.
  • Bougnoux ME, Kac G, Aegerter P, et al. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008;34(2):292–299. doi: 10.1007/s00134-007-0865-y.
  • Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839–845. doi: 10.1007/s00134-014-3310-z.
  • Bassetti M, Giacobbe DR, Vena A, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23(1):219. doi: 10.1186/s13054-019-2497-3.
  • Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi: 10.1086/421946.
  • Pappas PG, Lionakis MS, Arendrup MC, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018;4(1):18026. doi: 10.1038/nrdp.2018.26.
  • Bassetti M, Giacobbe DR, Vena A, et al. Diagnosis and treatment of candidemia in the intensive care unit. Semin Respir Crit Care Med. 2019;40(4):524–539. doi: 10.1055/s-0039-1693704.
  • Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43(1):25–31. doi: 10.1086/504810.
  • Bassetti M, Molinari MP, Mussap M, et al. Candidaemia in internal medicine departments: the burden of a rising problem. Clin Microbiol Infect. 2013;19(6):E281–E284. doi: 10.1111/1469-0691.12155.
  • Johnson MD, Lewis RE, Dodds Ashley ES, et al. Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020;222(Suppl 3):S175–S198. doi: 10.1093/infdis/jiaa394.
  • Giacobbe DR, Signori A, Tumbarello M, et al. Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia. Eur J Clin Microbiol Infect Dis. 2019;38(2):413–417. doi: 10.1007/s10096-018-3441-1.
  • Yera H, Sendid B, Francois N, et al. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis. 2001;20(12):864–870. doi: 10.1007/s100960100629.
  • White PL, Archer AE, Barnes RA. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J Clin Microbiol. 2005;43(5):2181–2187. doi: 10.1128/JCM.43.5.2181-2187.2005.
  • Wei S, Wu T, Wu Y, et al. Diagnostic accuracy of Candida albicans germ tube antibody for invasive candidiasis: systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2019;93(4):339–345. doi: 10.1016/j.diagmicrobio.2018.10.017.
  • Walker B, Powers-Fletcher MV, Schmidt RL, et al. Cost-effectiveness analysis of multiplex PCR with magnetic resonance detection versus empiric or blood culture-directed therapy for management of suspected candidemia. J Clin Microbiol. 2016;54(3):718–726. doi: 10.1128/JCM.02971-15.
  • Rouze A, Loridant S, Poissy J, et al. Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial. Intensive Care Med. 2017;43(11):1668–1677. doi: 10.1007/s00134-017-4932-8.
  • Raineri SM, Cortegiani A, Vitale F, et al. Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence? J Intensive Care. 2017;5(1):58. doi: 10.1186/s40560-017-0252-x.
  • Posteraro B, Tumbarello M, De Pascale G, et al. (1,3)-beta-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. J Antimicrob Chemother. 2016;71(8):2262–2269. doi: 10.1093/jac/dkw112.
  • Posteraro B, De Pascale G, Tumbarello M, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1–>3)-beta-D-glucan assay, Candida score, and colonization index. Crit Care. 2011;15(5):R249. doi: 10.1186/cc10507.
  • Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol. 2005;43(3):235–243. doi: 10.1080/13693780410001731619.
  • Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007;26(4):271–276. doi: 10.1007/s10096-007-0270-z.
  • Mikulska M, Magnasco L, Signori A, et al. Sensitivity of serum Beta-D-Glucan in candidemia according to Candida species epidemiology in critically ill patients admitted to the Intensive Care Unit. J Fungi (Basel). 2022;8(9):921. doi: 10.3390/jof8090921.
  • Mikulska M, Giacobbe DR, Furfaro E, et al. Lower sensitivity of serum (1,3)-beta-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis. Clin Microbiol Infect. 2016;22(7):646.e5–646.e8. doi: 10.1016/j.cmi.2016.05.020.
  • Martinez-Jimenez MC, Munoz P, Valerio M, et al. Candida biomarkers in patients with candidaemia and bacteraemia. J Antimicrob Chemother. 2015;70(8):2354–2361. Augdoi: 10.1093/jac/dkv090.
  • Leon C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730–737. doi: 10.1097/01.CCM.0000202208.37364.7D.
  • Giannella M, Paolucci M, Roncarati G, et al. Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-Centre study. J Antimicrob Chemother. 2018;73(10):2856–2859. doi: 10.1093/jac/dky247.
  • Giacobbe DR, Mikulska M, Tumbarello M, et al. Combined use of serum (1,3)-beta-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21(1):176. doi: 10.1186/s13054-017-1763-5.
  • Arendrup MC, Andersen JS, Holten MK, et al. Diagnostic performance of T2Candida among ICU patients with risk factors for invasive candidiasis. Open Forum Infect Dis. 2019;6(5):ofz136. doi: 10.1093/ofid/ofz136.
  • Yoo J, Kim SH, Hur S, et al. Candidemia risk prediction (CanDETEC) model for patients with malignancy: model development and validation in a single-center retrospective study. JMIR Med Inform. 2021;9(7):e24651. doi: 10.2196/24651.
  • Ripoli A, Sozio E, Sbrana F, et al. Personalized machine learning approach to predict candidemia in medical wards. Infection. 2020;48(5):749–759. doi: 10.1007/s15010-020-01488-3.
  • Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262–e273. doi: 10.1016/S1470-2045(19)30149-4.
  • Giacobbe DR, Signori A, Del Puente F, et al. Early detection of sepsis With machine learning techniques: a brief clinical perspective. Front Med (Lausanne). 2021;8:617486. doi: 10.3389/fmed.2021.617486.
  • Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319(13):1317–1318. doi: 10.1001/jama.2017.18391.
  • Mora S, Giacobbe DR, Russo C, et al. A wide database for future studies aimed at improving early recognition of candidemia. Stud Health Technol Inform. 2021;281:1081–1082.
  • Giacobbe DR, Mora S, Signori A, et al. Validation of an automated system for the extraction of a wide dataset for clinical studies aimed at improving the early diagnosis of candidemia. Diagnostics (Basel). 2023;13(5):961. doi: 10.3390/diagnostics13050961.
  • Kim SH, Yoon YK, Kim MJ, et al. Risk factors for and clinical implications of mixed candida/bacterial bloodstream infections. Clin Microbiol Infect. 2013;19(1):62–68. Jandoi: 10.1111/j.1469-0691.2012.03906.x.
  • ECDC. Healthcare-Associated Infections Acquired in Intensive Care Units. Annual Epidemiological Report for 2017 [cited 2023 Jun 24]. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-HAI.pdf
  • AUTO-CAND source code. https://github.com/AUTOCAND/AUTO-CAND.git
  • Heymans MW, Twisk JWR. Handling missing data in clinical research. J Clin Epidemiol. 2022;151:185–188. doi: 10.1016/j.jclinepi.2022.08.016.
  • Faisal S, Tutz G. Multiple imputation using nearest neighbor methods. Inf Sci. 2021;570:500–516. doi: 10.1016/j.ins.2021.04.009.
  • Fagan TJ. Letter: nomogram for bayes theorem. N Engl J Med. 1975;293(5):257.